Dr. Borgen on the Evolution of Breast Cancer Treatment
Patrick I. Borgen, MD, chairman of surgery, director of the Breast Cancer Program, Maimonides Medical Center, and chair of the Miami Breast Cancer Conference, discusses the evolution of breast cancer treatment in recent years. Borgen shared his insight in an interview during the meeting.
Patrick I. Borgen, MD, chairman of surgery, director of the Breast Cancer Program, Maimonides Medical Center, and chair of the Miami Breast Cancer Conference, discusses the evolution of breast cancer treatment in recent years. Borgen shared his insight in an interview with OncLive during the meeting.
This year's meeting illustrates how rapidly the field of breast cancer is evolving, Borgen explains. The conference included more than 90 lectures spanning topics that included genetic testing, optimal therapies for breast cancer subtypes, immunotherapy, breast cancer screening, neoadjuvant treatment, surgical advances, chemoprevention, PARP inhibition, and many more components of the breast cancer treatment landscape.
This, Borgen says, tells the oncology community how quickly the field is changing. Due to late-breaking news and clinical trial findings, there were a number of programs and discussions that were tailored to highlighting these advances.
This is a field in evolution in which Borgen says is exciting, yet challenging. The changes are a reemphasis the importance of the Miami Breast Cancer Conference, he concludes.
